variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
CFTR-G576A,CFTR,Associated with causing congenital bilateral absence of the vas deferens in a recessive manner. Reported cases were compound heterozygous with CFTR-F508Del.,High,Likely,Pathogenic,0.0047,Other,Recessive,Heterozygous,1545465;12719375,rs1800098,5,chr7,117230454,C,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
FLG-R501X,FLG,"Causes ichthyosis vulgaris in a recessive manner (sometimes homozygously, and sometimes compound heterozygously combined with another deleterious variant in this gene). Heterozygous carriers may be very prone to atopic dermatitis (a type of eczema) with moderately high penetrance (30-50% of carriers having symptoms according to Palmer et al.).",Moderate,Well-established,Pathogenic,0.013,Skin,Recessive,Heterozygous,16444271;16550169;16815158;17030239,,5,chr1,152285861,A,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
rs5186,,"This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.",Low,Likely,Pathogenic,0.21,Drug response;Heart and circulatory,Unknown,Heterozygous,"8021009;
11250978;11593098;16046653;16675453;17668390",rs5186,2,chr3,148459988,C,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
KRT5-G138E,KRT5,"This variant is associated with 1.25x increased risk of basal cell carcinoma (common skin cancer, rarely malignant).",Low,Likely,Pathogenic,0.052,Cancer;Skin,Unknown,Heterozygous,19578363,rs11170164,3,chr12,52913668,T,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
MBL2-R52C,MBL2,"This variant is associated with mannose binding protein deficiency which leads to impaired complement system immune response to mannose-rich pathogens. Patients homozygous for this allele or compound heterozygous are likely to have increased susceptibility to infection, but Hellemann et al. report heterosis for intensive care outcomes in heterozygous subjects. The wild-type version of this gene is known as variant allele A, while this is called variant allele D. See G54D (variant B) and G57E (variant C).",Low,Likely,Pathogenic,0.049,Immune system,Recessive,Heterozygous,7564730;10199352;17872904,rs5030737,1,chr10,54531242,A,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
RNASEL-R462Q,RNASEL,"Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.",Low,Uncertain,Pathogenic,0.28,Cancer;Genital and urinary,Complex/Other,Heterozygous,11941539;12022038;12415269;17407163,rs486907,2,chr1,182554557,T,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
TGFB1-R25P,TGFB1,"This variant in a growth factor gene is associated with variation in TGFB1 levels; this has been associated with various pathogenic and some protective effects, including: more hepatic fibrosis progression in hep C patients, lower risk of cleft palate, anticorrelation with longevity, higher risk of myocardial infarction and lower risk of hypertension.",Low,Uncertain,Pathogenic,0.049,Anatomical and congenital;Heart and circulatory,Complex/Other,Heterozygous,8901839;14596813;15212689;15569360,rs1800471,2,chr19,41858876,G,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
H6PD-R453Q,H6PD,"This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).",Low,Uncertain,Pathogenic,0.31,Genital and urinary;Metabolism,Recessive,Heterozygous,12858176;15827106;16817821,rs6688832,1,chr1,9323910,A,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
DYX1C1-E417X,DYX1C1,"One study reports this variant to be associated with dyslexia. The study group was relatively small and so the results did not have strong significance. If they are representative this variant is associated with a doubled risk for dyslexia, but it is unclear whether the effect would be additive, dominant, or recessive.",Low,Uncertain,Pathogenic,0.2,Mental and behavioral,Unknown,Heterozygous,12954984,rs57809907,3,chr15,55722882,A,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Heterozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
rs1544410,,"rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ",Low,Uncertain,Pharmacogenetic,0.35,Other,Unknown,Heterozygous,,rs1544410,0,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
ABCC6-R1268Q,ABCC6,This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.,Low,Uncertain,Pharmacogenetic,0.22,Metabolism,Unknown,Heterozygous,10811882;10913334;11776382;20038957,rs2238472,1,chr16,16251599,T,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Heterozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Heterozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Heterozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Heterozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
TOR1A-D216H,TOR1A,This SNP has been shown to be benign and play a protective role against Dystonia.  ,Low,Likely,Protective,0.1,Nervous system,Unknown,Heterozygous,18519876;19380705;20669276,rs1801968,1,chr9,132580901,G,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
LIG4-A3V,LIG4,One report has associated this with a decreased risk of multiple myeloma.,Low,Uncertain,Protective,0.036,Cancer,Dominant,Heterozygous,12471202,rs1805389,1,chr13,108863609,A,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
IRS2-G1057D,IRS2,"a.k.a Gly1057Asp, insulin receptor substrate-2 IRS2. The rs1805097(G) allele is associated with the Gly, and the (A) allele with Asp. 
A longevity study concluded that rs1805097(A;A) individuals were about twice as likely to live over 85 y/o (odds ratio 2.03, CI:1.39-2.99, p = .0003). ",Low,Uncertain,Protective,0.23,Other,Unknown,Heterozygous,19887537,rs1805097,,chr13,110435231,T,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
ARSA-N350S,ARSA,This common variant (HapMap 24.1% allele frequency) causes a loss of a glycosylation site (affecting the size of the protein when studied with gel electrophoresis) but does not affect enzyme activity or stability.,Low,Well-established,Benign,0.18,Other,Unknown,Heterozygous,2574462,rs2071421,,chr22,51064416,C,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
ADA-D8N,ADA,"This common variant is reported to reduce adenosine deaminase enzyme activity. It has been associated with an increased tendency for non-REM sleep -- more slow wave sleep, less nocturnal wakings, and a stronger negative impact of sleep deprivation. A role for this gene and variant was previously proposed for autism susceptibility, but this is controversial and was not replicated by later studies.",Low,Likely,Benign,0.03,Nervous system,Dominant,Heterozygous,7316475;8031011;11354825;16221767;17340203;21359089;21734253,rs73598374,,chr20,43280227,T,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
OCA2-R419Q,OCA2,"This variant is associated with eye color, as is OCA2 R305W. Individuals with this variant are reported to be more likely to have green/hazel eyes as opposed to blue/gray eyes. Other variants in this gene are associated with oculocutaneous albinism (albinism which involves skin and eyes).",Low,Likely,Benign,0.057,Hearing and vision;Skin,Unknown,Heterozygous,12163334,rs1800407,,chr15,28230318,T,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
EFHC1-R182H,EFHC1,Probably benign. OMIM appears to incorrectly interpret literature as linking this variant to juvenile myoclonic epilepsy; the authors report it as a polymorphism.,Low,Likely,Benign,0.044,Nervous system,Unknown,Heterozygous,7668263;15258581,rs3804505,,chr6,52303361,A,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
CACNA1S-L458H,CACNA1S,Common polymorphism,Low,Likely,Benign,0.27,Other,Unknown,Heterozygous,,rs12742169,,chr1,201052310,T,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Heterozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
COL4A4-G999E,COL4A4,"This variant is causative for Benign Familial Hematuria (thin membrane basement disease). While this variant is benign, it is useful in differentiating glomerular hematuria from Alport Syndrome.",Low,Uncertain,Benign,0.01,Blood,Dominant,Heterozygous,12631110;14871398,rs13027659,,chr2,227915847,T,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
POLG-Y831C,POLG,"A rare polymorphism in POLG, probably benign. A small study of a nuclear family hypothesized it was causing Parkinson disease, but a later study found no significant difference in incidence between cases (1/140) and controls (5/127).",Low,Uncertain,Benign,0.008,Nervous system,Unknown,Heterozygous,15534189;17846414,rs41549716,,chr15,89865073,C,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
FKTN-N446D,FKTN,Probably benign.,Low,Uncertain,Benign,0.009,Other,Unknown,Heterozygous,,rs41313301,,chr9,108397495,G,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
CYP27A1-P384L,CYP27A1,"Probably not pathogenic. Although predicted to be disruptive and treated by some as pathogenic, reports of this variant in cases were all linked with an upstream frameshift variant -- this supports the variant as a nonpathogenic ancestral polymorphism.",Low,Uncertain,Benign,0.018,Other,Unknown,Heterozygous,"
7860076;10775536;16500955",rs41272687,,chr2,219678877,T,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
DYNC2H1-Q304L,DYNC2H1,Presumed benign.,Low,Uncertain,Benign,0.048,Other,Unknown,Heterozygous,,rs12146610,,chr11,102988504,T,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
COL5A2-P460S,COL5A2,"Tentatively benign. Although predicted to be damaging by Polyphen 2, this variant is seen in 2 out of 62 PGP & public genomes. OMIM lists other more disruptive variants (frameshift & nonsense) as reported to cause Ehlers-Danlos syndrome when homozygous.",Low,Uncertain,Benign,0.04,"Muscular, skeletal, and connective tissue",Unknown,Heterozygous,,rs35830636,,chr2,189932764,A,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
FANCA-S1088F,FANCA,"Probably benign. One report hypothesized this variant causing Fanconi Anemia, but the allele frequency (3-7%) is high enough to contradict a highly penetrant pathogenic effect. Later authors have concluded this is a polymorphism, not pathogenic.",Low,Uncertain,Benign,0.058,Blood,Unknown,Heterozygous,10094191;14695169,rs17233497,0,chr16,89815152,A,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
DSPP-R68W,DSPP,"Probably benign. One report linked this to causing dentinogenesis Imperfecta type II in a large Swedish family, but subsequent publications have observed this is a common variant and conclude it is a nonpathogenic polymorphism.",Low,Uncertain,Benign,0.14,"Mouth, liver, and digestive",Unknown,Heterozygous,14758537;17452557;18797159,rs36094464,,chr4,88533540,T,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
CASP8-M1T,CASP8,"Probably benign. Although start codons can be extremely disruptive and this gene is implicated in a rare disease (autoimmune lymphoproliferative syndrome), the allele frequency for this variant (2-3%) is high enough to contradict such a strong pathogenic effect. This may be because the gene has many other transcripts that do not include this position as exonic.",Low,Uncertain,Benign,0.031,Blood;Immune system,Unknown,Heterozygous,12353035,rs3769824,,chr2,202122956,C,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
MAPT-R370W,MAPT,Probably benign.,Low,Uncertain,Benign,0.16,Other,Unknown,Heterozygous,15365985,rs17651549,,chr17,44061278,T,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
NOTCH3-H1133Q,NOTCH3,Probably benign.,Low,Uncertain,Benign,0.013,Other,Unknown,Heterozygous,9388399,rs112197217,,chr19,15290236,T,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Homozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Homozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
PHYH-P29S,PHYH,"Probably benign. This variant was implicated as causing Refsum Disease in a recessive manner, but a subsequent publication noted that all instances were linked with other explanatory mutations. The high allele frequency of this variant in the population (7-13%) contradicts a pathogenic hypothesis.",Low,Uncertain,Benign,0.16,Nervous system,Unknown,Heterozygous,10767344;14974078,rs28938169,0,chr10,13340236,A,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Heterozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.personalgenomes.org/genomes?display_genome_id=d56f01b59b16d794d458fdd1f7bb673c6cef617a&access_token=d9ba230ab67b8adc66be11856aeb86e4
